Home > Boards > US Listed > Medical - Drugs > NovaBay Pharmaceuticals, Inc. (NBY)

News: $NBY NovaBay Pharmaceuticals Reports 2019 Second Quarter

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
whytestocks Member Profile
Member Level 
Followed By 55
Posts 6,987
Boards Moderated 1
Alias Born 06/04/18
160x600 placeholder
NovaBay Pharmaceuticals Launches NovaWipes Eyelid Wipes on Amazon.com Business Wire - 12/2/2019 6:50:00 AM
NovaBay Pharmaceuticals Launches NovaSight™ Daily Vitamin for Ocular Health on Amazon.com Business Wire - 11/18/2019 6:50:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/7/2019 4:14:21 PM
NovaBay Pharmaceuticals Reports 2019 Third Quarter Financial Results Business Wire - 11/7/2019 4:05:00 PM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 11/6/2019 6:00:59 AM
NovaBay Pharmaceuticals Launches Online Sales of CelleRx® Skin Cleanser for Post-Aesthetic Dermatology & Cosmetic Surgery Pr... Business Wire - 11/4/2019 6:50:00 AM
NovaBay Pharmaceuticals to Hold Third Quarter 2019 Conference Call on November 7, 2019 Business Wire - 10/31/2019 6:50:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/30/2019 4:32:21 PM
Amended Statement of Changes in Beneficial Ownership (4/a) Edgar (US Regulatory) - 10/28/2019 4:31:11 PM
Amended Statement of Changes in Beneficial Ownership (4/a) Edgar (US Regulatory) - 10/28/2019 4:30:07 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/28/2019 4:29:15 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/28/2019 4:28:09 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/28/2019 4:26:27 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/28/2019 4:26:12 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/28/2019 4:25:26 PM
NovaBay Pharmaceuticals to Distribute the NuLids System® for the Treatment of Dry Eye in Certain U.S. Geographies Business Wire - 10/28/2019 6:50:00 AM
Securities Registration Statement (s-1) Edgar (US Regulatory) - 10/25/2019 4:33:12 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/10/2019 4:31:16 PM
NovaBay Pharmaceuticals Receives Approval for Distribution of Avenova in Australia Business Wire - 9/24/2019 6:50:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/16/2019 4:31:08 PM
NovaBay Pharmaceuticals Names Finance Executive Jeff Zheng to its Board of Directors Business Wire - 9/16/2019 6:50:00 AM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 9/13/2019 8:31:28 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 9/13/2019 6:01:18 AM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 9/4/2019 4:33:03 PM
NovaBay Pharmaceuticals to Present at Two Investment Conferences in September Business Wire - 9/3/2019 6:50:00 AM
whytestocks Member Level  Monday, 07/29/19 09:50:26 AM
Re: None
Post # of 893 
News: $NBY NovaBay Pharmaceuticals Reports 2019 Second Quarter Net Sales of $1.8 Million

Company to hold second quarter 2019 conference call on August 8 NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing Avenova ® for the domestic eye care market, reports net sales of $1.8 million for the three months...

In case you are interested NovaBay Pharmaceuticals Reports 2019 Second Quarter Net Sales of $1.8 Million

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist